↓ Skip to main content

Pricing Cancer Drugs: When Does Pricing Become Profiteering?

Overview of attention for article published in The AMA Journal of Ethic, August 2015
Altmetric Badge

Mentioned by

twitter
19 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
25 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pricing Cancer Drugs: When Does Pricing Become Profiteering?
Published in
The AMA Journal of Ethic, August 2015
DOI 10.1001/journalofethics.2015.17.8.nlit1-1508
Pubmed ID
Authors

Hannah L Kushnick

X Demographics

X Demographics

The data shown below were collected from the profiles of 19 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Turkey 1 4%
Unknown 24 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 28%
Student > Master 5 20%
Student > Bachelor 3 12%
Student > Postgraduate 2 8%
Professor 1 4%
Other 2 8%
Unknown 5 20%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 7 28%
Medicine and Dentistry 5 20%
Economics, Econometrics and Finance 3 12%
Agricultural and Biological Sciences 1 4%
Social Sciences 1 4%
Other 3 12%
Unknown 5 20%